Shionogi Co-promotes Flu Diagnostic Kit Along With Peramivir
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Shionogi started co-promoting a flu virus diagnostic kit developed by Tokyo-based Mizuho Medy in Japan. The Quick Chaser Flu A,B can quickly detect the flu virus and will be marketed along with Shionogi's newly launched flu drug Rapiacta (peramivir) injection. The co-promotion deal will enable Shionogi to provide flu patients with a full line of services from detection to treatment. The diagnostic kit is priced at ¥11,000 for 10 uses. (Click here for more - Japanese language
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.